Processa Pharmaceuticals
PCSA
PCSA
9 hedge funds and large institutions have $251K invested in Processa Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
9
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$115K | |
| 2 | +$54.8K | |
| 3 | +$30K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$10.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$414 |
Top Sellers
| 1 | -$106K | |
| 2 | -$40.8K | |
| 3 | -$25.7K | |
| 4 |
CBA
Coastal Bridge Advisors
Westport,
Connecticut
|
-$21.7K |
| 5 |
Renaissance Technologies
New York
|
-$19K |